• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in

Blog

Featured post

Regulatory-grade device evidence reimagined with new precision data

By linking unique device identifier (UDI) data with minute-level Admission–Discharge–Transfer (ADT), procedure logs, and chargemaster data, Truveta delivers the full picture of when, how, and in what context devices are used—accelerating regulatory submissions, health economics and outcomes research (HEOR), safety monitoring, and more.

Read more
RWD RWE medical device research safety effectiveness HEOR EHR chargemaster unique device identifier ADT ICU procedure logs
Research
Data
Technology
News & events
Recently, researchers published new insights in Diabetes using Truveta Data that explores the use of continuous glucose monitoring (CGM) in patients with type 2 diabetes (T2D) prior to and after initiating GLP-1 medications.
Research

Truveta Data used in new study finds increased use of CGM in patients with type 2 diabetes initiating GLP-1 medications

  • Truveta staff
  • July 2, 2024
Truveta healthcare AI technology ensures accuracy and explainability while assuring fairness and avoiding bias
Technology

Delivering accuracy and explainability for AI

  • Truveta staff
  • July 1, 2024
Truveta announced advanced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. Truveta offers the most complete, timely, and clean regulatory-grade electronic health record (EHR) data from more than 100 million patients across 30 US health systems, empowering researchers to study all diseases, drugs, and devices.
DataNews

Truveta supports regulatory submissions to the FDA and global regulatory authorities

  • Truveta staff
  • June 17, 2024
migraine research and migraine treatment from EHR real world data
Data

Migraine research unveiled: Insights from real-world EHR data and notes

  • Truveta staff
  • June 14, 2024
PSA testing, prostate-specific antigen testing, EHR data, prostate cancer screening
ResearchResearch Insights

Trends in PSA testing to screen for prostate-related conditions, including cancer

  • Truveta Research
  • June 10, 2024
AI large language model
Technology

Generating data gravity

  • Truveta staff
  • May 30, 2024
Truveta Research uses EHR data to monitor GLP-1 RA prescription trends.
Research

Monitoring GLP-1 RA prescription trends

  • Truveta staff
  • May 28, 2024
Truveta Research explores the ongoing trends in norovirus and rotavirus hospitalizations and test positivity rates.
Research

Real-time monitoring of viral gastroenteritis: April 2024

  • Truveta Research
  • May 22, 2024
prostate cancer data from the most complete EHR dataset
Data

New insights from family history can shed light on prostate cancer

  • Truveta staff
  • May 20, 2024
« Previous 1 … 13 14 15 16 17 … 41 Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.